CorMedix (CRMD) Operating Income (2016 - 2025)
Historic Operating Income for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $51.3 million.
- CorMedix's Operating Income rose 166193.24% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.0 million, marking a year-over-year increase of 32716.67%. This contributed to the annual value of -$22.4 million for FY2024, which is 5433.54% up from last year.
- Per CorMedix's latest filing, its Operating Income stood at $51.3 million for Q3 2025, which was up 166193.24% from $19.5 million recorded in Q2 2025.
- CorMedix's 5-year Operating Income high stood at $51.3 million for Q3 2025, and its period low was -$16.7 million during Q1 2024.
- Its 5-year average for Operating Income is -$1.4 million, with a median of -$7.5 million in 2021.
- Per our database at Business Quant, CorMedix's Operating Income tumbled by 5666.4% in 2023 and then surged by 166193.24% in 2025.
- Quarter analysis of 5 years shows CorMedix's Operating Income stood at -$7.8 million in 2021, then fell by 7.83% to -$8.4 million in 2022, then decreased by 24.77% to -$10.5 million in 2023, then surged by 223.59% to $12.9 million in 2024, then soared by 296.92% to $51.3 million in 2025.
- Its Operating Income was $51.3 million in Q3 2025, compared to $19.5 million in Q2 2025 and $20.1 million in Q1 2025.